下颌下腺癌:特定特征与治疗考量
该研究回顾了2000至2010年间在赫尔辛基大学医院接受手术的下颌下腺癌患者,最少随访5年。5年疾病特异性生存率和总生存率均为76%,无病生存率为68%。结论认为该病罕见且组织学模式多变,适合集中化管理。
要点
- 下颌下腺癌占下颌下腺肿瘤的30%,腺样囊性癌最常见(56%)。
- 颈清扫标本中20%存在转移,隐匿性转移率仅4%。
- 5年DSS和OS均为76%,DFS为68%,复发率44%。
核心结论
- 多数下颌下腺癌为腺样囊性癌,组织学模式与腮腺癌不同。
- 隐匿性转移罕见,但复发率较高且远处转移常见。
- 因罕见、组织学多变及生物学行为差异,建议集中化管理。
研究设计与样本
- 回顾性队列研究,纳入2000至2010年赫尔辛基大学医院所有接受手术的下颌下腺癌患者,最少随访5年。
主要发现
- 腺样囊性癌占56%,初诊时仅3例有 probable malignancy 的临床征象。
- 22例颈清扫标本中5例(20%)有转移,隐匿性转移率为4%。
- 11例(44%)复发,其中7例(28%)仅为远处部位复发。
- 5年疾病特异性生存率和总生存率均为76%,无病生存率为68%。
临床怎么用
- 对下颌下腺癌应警惕腺样囊性癌可能,治疗需考虑其不同于腮腺癌的生物学行为。
- 颈清扫决策需权衡较低的隐匿性转移率(4%)。
- 鉴于复发和远处转移风险,建议集中化管理并加强随访。
局限性
- 未报告统一治疗协议,存在选择偏倚可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the absence of unified treatment protocol, we evaluated the management and outcomes of submandibular gland cancers in an unselected patient series. METHODS: We included all patients with resected submandibular gland cancer treated at the Helsinki University Hospital from 2000 to 2010 with a 5-year minimum follow-up. RESULTS: Twenty-five patients with cancer represented 30% of submandibular gland neoplasms, and most were adenoid cystic carcinomas (ACCs; 56%). At presentation, 3 patients showed clinical signs of probable malignancy. Of 22 neck dissection specimens, 5 patients (20%) had metastases with an occult metastasis rate of 4%. Cancer recurred in 11 patients (44%), of which 7 (28%) were only at a distant site. The 5-year disease-specific survival (DSS) and overall survival (OS) rates were 76%, and disease-free survival (DFS) was 68%. CONCLUSION: Most tumors were ACCs differing from the histological pattern of parotid gland cancers. Occult metastases were rare. The rarity of submandibular gland cancer, its variable histological pattern, and varying biological behavior warrant centralized management.
引用
- Aro K, Tarkkanen J, Saat R, et al. Submandibular gland cancer: Specific features and treatment considerations. Head Neck. 2017. PMID: 29083518. doi:10.1002/hed.24981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。